Show results for
Refine by
Drug Design With Structure Based Drug Design Services In Europe
8 services found
by:CrystalsFirst GmbH based inMarburg, GERMANY
We also provide consulting services for the target-to-hit phase and structurally-enabled campaigns. Our cutting-edge solutions, collaborative culture, speed and agility, enable us to move with you in the direction, that will best suit your quest for success. Fragment-based drug design relies heavily on the availability of ...
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
Drug design is engineering at the molecular scale. Every position of every atom and every bond determines the future success of a ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
The nucleic acid drug, as a novel therapeutic modality, can achieve long-lasting or even curative effects via gene regulations, replacement or editing. They have great potential to treat human diseases such as viral infections, cancers, and genetic ...
Manufactured by:Recipharm AB based inStockholm, SWEDEN
Give your drug delivery device development the expert support it needs. Bespak by Recipharm has the expertise and capabilities to bring your drug delivery device designs to life. We produce innovative and high-quality devices for the world’s leading pharmaceutical companies, from initial pilot scale-up, to large-scale ...
by:International Drug Development Institute (IDDI) based inLouvain-la-Neuve, BELGIUM
Aiming at optimizing your clinical development strategy, our expert consultants develop the innovative strategies and capabilities needed to launch products with the greatest potential for commercial success and improved patient outcomes. ...
by:Molecular Health GmbH based inHeidelberg, GERMANY
Act beyond human and experimental limitations. Knowledge to advance game-changing therapies from idea to market. The world's biomedical knowledge at your fingertips. Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Acute Radiation Syndrome (ARS) involves severe, potentially lethal damage to the bone marrow’s ability to produce blood cells, as well as to other systems and organs. Severe damage to bone marrow makes victims vulnerable to life-threatening hemorrhage, infection and anemia. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Bone marrow deficiency refers to a condition in which the hematopoietic stem cells in the bone marrow fail to produce enough, or produce abnormal, red blood cells, white blood cells and platelets. Hematopoietic cell transplantation (HCT), the transplantation of multipotent hematopoietic cells, is a standard treatment in various malignant and non-malignant conditions. Transplant patients are ...